These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16737044)

  • 1. Management of chronic hepatitis B: the Indian perspective.
    Acharya SK
    Trop Gastroenterol; 2005; 26(4):171-2. PubMed ID: 16737044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)].
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K
    Przegl Epidemiol; 2008; 62(2):379-81. PubMed ID: 18807484
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hepatitis B virus infection in the underprivileged world.
    Almasio PL; Craxì A
    Liver Int; 2011 Jul; 31(6):749-50. PubMed ID: 21645204
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic hepatitis B.
    Lok AS; McMahon BJ
    Hepatology; 2007 Feb; 45(2):507-39. PubMed ID: 17256718
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
    Mauss S; Wedemeyer H
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline on prevention and treatment of chronic hepatitis B in China (2005).
    ;
    Chin Med J (Engl); 2007 Dec; 120(24):2159-73. PubMed ID: 18167196
    [No Abstract]   [Full Text] [Related]  

  • 7. An omission in the AASLD Practice Guidelines on Chronic Hepatitis B.
    Jhaveri R; Murray N
    Hepatology; 2007 Jul; 46(1):280; author reply 280. PubMed ID: 17596892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems of resistance during treatment of chronic hepapitis B with nucleoside and nucleotide analogues: diagnostics, prophylactics and treatment].
    Abdurakhmanov DT
    Eksp Klin Gastroenterol; 2007; (4):74-81. PubMed ID: 18411444
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B immunization after liver transplantation: what is the answer?
    Poland GA; Poterucha JJ
    Liver Transpl; 2005 Oct; 11(10):1181-3. PubMed ID: 16184563
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
    Kohrt HE; Ouyang DL; Keeffe EB
    Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming strategies to provide access to care.
    Jacobson IM; Wang S; Edlin BR; Smith VK; Chow EA
    J Fam Pract; 2010 Apr; 59(4 Suppl):S59-64. PubMed ID: 20398592
    [No Abstract]   [Full Text] [Related]  

  • 12. [A primer on the management of antiviral resistance in chronic hepatitis B].
    Doerig C; Sahli R; Telenti A; Moradpour D
    Rev Med Suisse; 2009 Jan; 5(187):203-4, 206-8,. PubMed ID: 19271431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.
    Tseng TC; Liu CJ; Kao JH
    Am J Gastroenterol; 2007 Jul; 102(7):1544; author reply 1545. PubMed ID: 17593169
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
    Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K;
    Przegl Epidemiol; 2013; 67(2):287-95, 383-91. PubMed ID: 24040735
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic hepatitis B infection: a workshop consensus statement and algorithm.
    McHugh JA; Cullison S; Apuzzio J; Block JM; Cohen C; Leong SL; London WT; McNellis RJ; Neubauer RL; Perrillo R; Squires R; Tarrant D; McMahon BJ
    J Fam Pract; 2011 Sep; 60(9):E1-8. PubMed ID: 21901174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 18. To define virological response in hepatitis B e antigen-negative patients.
    Ozaras R; Leblebicioglu H; Eroglu C
    Hepatology; 2008 Apr; 47(4):1425; author reply 1425-6. PubMed ID: 18322938
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotyping and genomic sequencing in clinical practice.
    Gish RG; Locarnini S
    Clin Liver Dis; 2007 Nov; 11(4):761-95, viii. PubMed ID: 17981228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
    Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.